FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

539811000001106: Seretide 250 Evohaler (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17224901000001114 Seretide 250 Evohaler (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58153501000001118 Seretide 250 Evohaler (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 250 Evohaler (GlaxoSmithKline) Is a Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has active ingredient Salmeterol false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has active ingredient Fluticasone false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Is a Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has manufactured dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Is a Seretide Evohaler true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has manufactured dose form Inhalation dosage form false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) VMP prescribing status (attribute) VMP not recommended to prescribe - patient training required false Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Has basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) Is a Fluticasone 250micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Is pack of False Seretide 250 Evohaler (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Seretide 250 Evohaler (GlaxoSmithKline) 120 dose Has AMP True Seretide 250 Evohaler (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start